Philadelphia Investment Partners »

Viking Therapeutics shares owned by Philadelphia Investment Partners

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Philadelphia Investment Partners from 13F filings

Historical chart of Philadelphia Investment Partners investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Philadelphia Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Philadelphia Investment Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.8k 250 39.01

More positions owned by Philadelphia Investment Partners

Vaneck Vectors Tr Fallen Angel Hg Etf (ANGL)
Vaneck Vectors Tr Morningstar Wide Etf (MOAT)
Spdr Series Trust Prtflo S&p500 Gw Etf (SPYG)
Freedom 100 Emerging Markets Etf etf (FRDM)
Ishares Tr Blackrock Etf (ICSH)
Palantir Technologies (PLTR)
Ishares Tr 3 7 Yr Treas Etf (IEI)
Dbx Tr Xtrak Msci Eafe Etf (DBEF)
NVIDIA Corporation (NVDA)
Vanguard Admiral Fds Inc Smllcp 600 Etf (VIOO)
J P Morgan Exchange Traded F Global Bd Etf (JPIB)
Apple (AAPL)
Blackstone Group Inc Com Cl A (BX)
JPMorgan Chase & Co. (JPM)
Centrus Energy Corp cl a (LEU)

View all positions for Philadelphia Investment Partners

Top funds holding Viking Therapeutics

FMR
BlackRock
Vanguard Capital Management
Susquehanna International
Vanguard Portfolio Management
Two Sigma Investments
Citadel Advisors
Ameriprise Financial
Geode Capital Management
Diadema Partners
American Century Companies
Jane Street
D. E. Shaw & Co
Bnp Paribas Arbitrage, Snc
Goldman Sachs Group

View all funds holding Viking Therapeutics